Follow
Christina Piperi, PhD (Oxford University)
Christina Piperi, PhD (Oxford University)
Professor of Biochemistry, National and Kapodistrian University of Athens, Medical School
Verified email at med.uoa.gr
Title
Cited by
Cited by
Year
Inflammatory process in type 2 diabetes: The role of cytokines
K Alexandraki, C Piperi, C Kalofoutis, J Singh, A Alaveras, A Kalofoutis
Annals of the New York Academy of Sciences 1084 (1), 89-117, 2006
4912006
Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin
E Diamanti-Kandarakis, T Paterakis, K Alexandraki, C Piperi, A Aessopos, ...
Human Reproduction 21 (6), 1426-1431, 2006
2862006
Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth
E Diamanti-Kandarakis, C Piperi
Human Reproduction Update 11 (6), 631-643, 2005
2282005
Metformin administration improves endothelial function in women with polycystic ovary syndrome
E Diamanti-Kandarakis, K Alexandraki, A Protogerou, C Piperi, ...
European Journal of Endocrinology 152 (5), 749-756, 2005
2062005
Increased serum advanced glycation end‐products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)
E Diamanti‐Kandarakis, I Katsikis, C Piperi, E Kandaraki, A Piouka, ...
Clinical endocrinology 69 (4), 634-641, 2008
2052008
Inflammatory and endothelial markers in women with polycystic ovary syndrome
E Diamanti‐Kandarakis, K Alexandraki, C Piperi, A Protogerou, I Katsikis, ...
European journal of clinical investigation 36 (10), 691-697, 2006
2042006
Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries
E Diamanti-Kandarakis, C Piperi, E Patsouris, P Korkolopoulou, D Panidis, ...
Histochemistry and cell biology 127 (6), 581-589, 2007
1972007
Type II diabetes mellitus and cardiovascular risk factors: current therapeutic approaches
C Kalofoutis, C Piperi, A Kalofoutis, F Harris, D Phoenix, J Singh
Experimental & Clinical Cardiology 12 (1), 17, 2007
1882007
Increased levels of serum advanced glycation end‐products in women with polycystic ovary syndrome
E Diamanti‐Kandarakis, C Piperi, A Kalofoutis, G Creatsas
Clinical endocrinology 62 (1), 37-43, 2005
1832005
Crosstalk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseases
C Piperi, C Adamopoulos, G Dalagiorgou, E Diamanti-Kandarakis, ...
The Journal of Clinical Endocrinology & Metabolism 97 (7), 2231-2242, 2012
1582012
Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation
KI Alexandraki, C Piperi, PD Ziakas, NV Apostolopoulos, K Makrilakis, ...
Journal of clinical immunology 28 (4), 314-321, 2008
1582008
Polycystic ovary syndrome: the influence of environmental and genetic factors
E Diamanti-Kandarakis, C Piperi, G Argyrakopoulou, J Spina, ...
HORMONES-ATHENS- 5 (1), 17, 2006
1572006
Emerging role of advanced glycation-end products (AGEs) in the pathobiology of eye diseases
SA Kandarakis, C Piperi, F Topouzis, AG Papavassiliou
Progress in retinal and eye research 42, 85-102, 2014
1342014
Increased plasma levels of 8-iso-PGF2α and IL-6 in an elderly population with depression
N Dimopoulos, C Piperi, V Psarra, RW Lea, A Kalofoutis
Psychiatry research 161 (1), 59-66, 2008
1252008
Accumulation of dietary glycotoxins in the reproductive system of normal female rats
E Diamanti-Kandarakis, C Piperi, P Korkolopoulou, E Kandaraki, ...
Journal of Molecular Medicine 85 (12), 1413-1420, 2007
1102007
Role of histone lysine methyltransferases SUV39H1 and SETDB1 in gliomagenesis: modulation of cell proliferation, migration, and colony formation
A Spyropoulou, A Gargalionis, G Dalagiorgou, C Adamopoulos, ...
Neuromolecular medicine 16 (1), 70-82, 2014
972014
Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling
YN Paudel, E Angelopoulou, C Piperi, VRMT Balasubramaniam, ...
European journal of pharmacology 858, 172487, 2019
942019
Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s disease (AD): from risk factors to therapeutic targeting
YN Paudel, E Angelopoulou, C Piperi, I Othman, K Aamir, MF Shaikh
Cells 9 (2), 383, 2020
882020
Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy
A Nikaki, C Piperi, AG Papavassiliou
Expert opinion on investigational drugs 21 (10), 1475-1488, 2012
882012
Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis
V Matzaraki, KI Alexandraki, K Venetsanou, C Piperi, P Myrianthefs, ...
Clinical biochemistry 40 (5-6), 336-342, 2007
842007
The system can't perform the operation now. Try again later.
Articles 1–20